The effects of anti-IL17 are mainly mediated by the reduction in expression of inflammatory cytokines, neutrophils and macrophages, suggesting that anti-IL17 can modulate the inflammatory, extracellular matrix remodeling and the oxidative stress balance in ALI. Here, IL17A is linked to acute respiratory distress syndrome.